Apollo Hospitals to join Ayushman Bharat, but only in smaller cities
In metropolitan cities, however, it will continue to stay away till the government programme raises the rates for surgery and treatment26-09-2019
26-09-2019
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Closure of Trading Window
Sub: Board Meeting for approval of unaudited financial results. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company will, inter alia, consider the approval of the unaudited financial results for the quarter and half year ending September 30, 2019 at its Meeting to be held on Thursday, November 14, 2019. Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window will remain closed from October 1, 2019 to November 16, 2019 (both days inclusive) for Directors and Designated Persons. Please take note of the above in your records.25-09-2019
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Board Meeting Intimation for Board Meeting For Approval Of Unaudited Financial Results.
APOLLO HOSPITALS ENTERPRISE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Sub: Board Meeting for approval of unaudited financial results. Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company will, inter alia, consider the approval of the unaudited financial results for the quarter and half year ending September 30, 2019 at its Meeting to be held on Thursday, November 14, 2019. Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window will remain closed from October 1, 2019 to November 16, 2019 (both days inclusive) for Directors and Designated Persons. Please take note of the above in your records.25-09-2019
CCI approves restructuring, sale of Apollo Hospitals' pharmacy business
In November, Apollo Hospitals had announced the restructuring and sale of its pharmacy operations.The restructuring would help Apollo Hospitals reduce its net debt23-09-2019
APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for PCR Investments Ltd23-09-2019
Apollo Hospitals Enterprise Ltd - 508869 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd20-09-2019
Apollo Hospitals in pact with US firm to launch healthcare drones
Apollo Hospitals Group has tied up with US-based Zipline to launch Drone healthcare delivery solutions. The Hospital will explore and leverage drone19-09-2019
Apollo Hospitals Enterprise Ltd - 508869 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, Sub: Intimation in terms of Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulations) regarding loss of share certificate. This is to inform you that the Company has received intimation from shareholder on September 18, 2019 regarding loss of share certificate. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificate are as given below: Folio No. Name of the Shareholder(s) No of equity shares held Share Certificate No. Distinctive Nos. 9849 Syed Basheer Ahamed H 150 359852 8084229 to 8084378 This is for your information.18-09-2019
Apollo Hospitals launches artificial intelligence-based programme
The programme, designed for three years now, would offer health check ups, directions and health mentoring17-09-2019
Apollo Hospitals to seek shareholders' nod for hiving off pharmacy biz
Front end of the business to go to a separate firm, which will focus on achieving Rs 10,000 cr revenue and 30% ROCE within 5 years16-09-2019